The abstract is read at the publisher; the summary is JClub's.
Racial and ethnic disparities in treatment discontinuation are examined in pregnant females with opioid use disorder (OUD) receiving buprenorphine or methadone in the US cohort.
- Why it matters: Discontinuation during pregnancy can undermine care for opioid use disorder, yet disparities by race and ethnicity in retention are not well characterized.
- What they did: In a US cohort study, retention in buprenorphine and methadone treatment was analyzed among pregnant females with OUD by race and ethnicity.
- The result: The study quantifies how retention differs across racial and ethnic groups, informing where treatment support may be needed to reduce discontinuation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.